Ask AI
ProCE Banner Events

Share

Movement Disorders+ Summit 2022 -  Day 2

Join us for this FREE live, virtual 2-day summit Friday, September 30 - Saturday, October 1, 2022, and earn up to 10 CME/CE credits.* Based on the overwhelming success of last year’s inaugural Movement Disorders Summit and feedback from our learners, we have expanded this year’s agenda to 2 days and are pleased to include several sessions on hot topics in neurology. You will not want to miss this exciting and informative conference featuring CCO’s expert faculty, who will cover the most recent advances in the identification and management of critical issues surrounding these disorders.

 

Register now for this state-of-the-art live, virtual summit!

 

*Credits offered for this program include AMA, ANCC, ACPE, and AAPA.

This event has expired. No longer available for credits.

Who Should Attend

This program is intended for a multidisciplinary audience of neurologists, psychiatrists, primary care physicians, nurses, physician associates/physician assistants, pharmacists, and other members of the healthcare team involved in the management of patients with neurologic and movement disorders.

Time and location

Wednesday, December 28, 2022 to Wednesday, February 01, 2023

9:55 AM - 3:50 PM Eastern Time (ET)

Virtual

Agenda

*Subject to change

 

All times are in Eastern Time.

 

Day 2: Saturday, October 1, 2022
All times are in ET

9:55 AM - 10:00 AM: Welcome Remarks - Rajesh Pahwa, MD (Chair)

10:00 AM - 11:00 AM: Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Stuart Isaacson, MD (FIU Herbert Wertheim College of Medicine)
In this session, we will review our current understanding of tardive dyskinesia, clinical pearls to distinguish it from other drug-induced movement disorders, and how assessment of the impact of tardive dyskinesia can aid treatment decisions with first-line VMAT2 inhibitor therapy.

- 5-min break -

11:05 AM - 12:05 PM: Managing Advanced Parkinson Disease: Adjunctive Therapies - Rajesh Pahwa, MD (University of Kansas Medical Center)
This session will focus on patients with Parkinson disease, motor fluctuation, and dyskinesia and the use of adjunctive therapies to levodopa to improve their OFF time and improve their good time during the day.

- 5-min break -

12:10 PM - 1:10 PM: Hyperkinetic Movement Disorders: Importance of Differential Diagnosis When Symptoms Overlap - Victor Sung, MD (University of Alabama School of Medicine at Birmingham)
This session will discuss the various hyperkinetic movements and will provide a framework to differentiate among the various disorders that cause them. In addition, a treatment algorithm will be discussed for the specific hyperkinetic movement of chorea caused by Huntington disease.

- 30-min break, including 5-min yoga session -

1:40 PM - 2:40 PM: Beyond Pharmacotherapy: Advancements in Surgical Therapies for Parkinson Disease - Marta San Luciano, MD (University of California San Francisco)
In this session, Dr. San Luciano will discuss the indications and appropriateness for surgical therapies in Parkinson disease. She will review the procedure, outcomes, benefit/risks, and current state of research of deep brain stimulation, carbidopa/levodopa intestinal gel therapy, and high frequency MR-guided focused ultrasound.

- 5-min break -

2:45 PM - 3:45 PM: Updates in Diagnosis and Treatment of Essential Tremor - Daniel E. Kremens, JD, MD (Thomas Jefferson University)
In this session, Dr. Kremens will review essential tremor, including the epidemiology and recent diagnostic criteria. He also will review current and emerging treatments for essential tremor including pharmacologic, surgical, and device-aided therapies.

3:45 PM - 3:50 PM: Closing Remarks - Rajesh Pahwa, MD (Chair)

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of neurological and movement disorders.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education

 

Credit Designation 

 

CCO designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity will be 10.0 contact hours, including 10.0 hours of pharmacology credit

 

Continuing Pharmacy Education

CCO designates this continuing education activity for 10.0 contact hours (1.0 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - UANs will be specific to each topic.

 

Type of Activity: Application

 

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

 

Physician Associate/Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

 

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity offers 10.0 continuing education credits for psychologists

 

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Supported by an educational grant from Teva Pharmaceuticals.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191